Share Price

Showing 3029 articles
Business

AbCellera Biologics: A Tale of Two Valuations Amid Steep Share Decline

Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.

Business

Plug Power Pushes Shareholders for Crucial Vote on Share Authorization, Citing Growth and Reverse Split Risks

In a detailed business update, Plug Power's CEO Andy Marsh made a direct appeal to shareholders to approve an increase in authorized shares, framing it as essential for meeting financial obligations and funding future growth. He warned that failure to pass the proposal would force the company to pursue a reverse stock split—a move he believes historically damages shareholder value.